These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21067600)

  • 1. Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.
    Hamidou Z; Causeret S; Dabakuyo TS; Gentil J; Arnould L; Roignot P; Altwegg T; Poillot ML; Bonnetain F; Arveux P
    BMC Cancer; 2010 Nov; 10():622. PubMed ID: 21067600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment.
    Dialla PO; Dabakuyo TS; Marilier S; Gentil J; Roignot P; Darut-Jouve A; Poillot ML; Quipourt V; Arveux P
    BMC Cancer; 2012 Oct; 12():472. PubMed ID: 23066863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin's lymphoma: time trends for incidence and survival in Côte-d'Or, France.
    Rolland-Portal I; Tazi MA; Milan C; Couillault C; Carli PM
    Int J Epidemiol; 1997 Oct; 26(5):945-52. PubMed ID: 9363514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations.
    Monnet E; Faivre J; Raymond L; Garau I
    Br J Cancer; 1999 Oct; 81(3):463-8. PubMed ID: 10507771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study.
    Leandersson P; Hogberg T; Dickman PW; Malander S; Borgfeldt C
    BMC Cancer; 2021 Apr; 21(1):465. PubMed ID: 33902507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors.
    Dabakuyo TS; Dialla O; Gentil J; Poillot ML; Roignot P; Cuisenier J; Arveux P
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):809-16. PubMed ID: 22642448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis of gynecological cancers in Southeast China, 2011-2020: A population-based study.
    Deng S; Zhou Y; Lin J; Xiang Z; Liu L; Xie N; Yu H; Sun Y
    Cancer Epidemiol; 2024 Oct; 92():102641. PubMed ID: 39167910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.
    Dabakuyo TS; Bonnetain F; Roignot P; Poillot ML; Chaplain G; Altwegg T; Hedelin G; Arveux P
    Ann Oncol; 2008 Feb; 19(2):276-83. PubMed ID: 17962200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in prehospital management of ST-segment elevation myocardial infarction from 2002 to 2010 in Cote d'Or: data from the RICO registry (obseRvatoire des Infarctus de Cote d'Or).
    Milojevitch E; Lorgis L; Falvo N; Buffet P; Boidron L; Dentan G; Avena C; Beer JC; Boudenia K; Zeller M; Freysz M; Cottin Y
    Arch Cardiovasc Dis; 2012 Dec; 105(12):649-55. PubMed ID: 23199620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
    Wong KH; Mang OW; Au KH; Law SC
    Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up.
    Bouchard-Fortier G; Panzarella T; Rosen B; Chapman W; Gien LT
    J Obstet Gynaecol Can; 2017 Jan; 39(1):34-41. PubMed ID: 28062021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution of therapeutic practices and survival of ovarian cancer in Bourgandi between 1982-1996: a registry-based study].
    Benoit L; Désir JP; Fraisse J; Arnould L; Cuisenier J
    Ann Chir; 2004 Oct; 129(8):415-21. PubMed ID: 15388369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends in oesophageal cancer incidence in Côte d'Or (France), 1976-93.
    Liabeuf A; Faivre J
    Eur J Cancer Prev; 1997 Feb; 6(1):24-30. PubMed ID: 9161809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland.
    Levi F; Franceschi S; La Vecchia C; Ruzicka J; Gloor E; Randimbison L
    Ann Oncol; 1993 Apr; 4(4):289-94. PubMed ID: 8518218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].
    Coudert B; Chaplain G; Milan C; Janoray P
    Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
    Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
    Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence, diagnosis, treatment and prognosis of cancer of the pancreas: development in Côte-d'Or from 1976 to 1985].
    Moutet JP; Arveux P; Kurdi E; Hillon P; Faivre J
    Bull Cancer; 1991; 78(4):323-30. PubMed ID: 1859901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.